Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |